WEIFANG, China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai Pharmaceutical" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced its CFO, Mr. Yizhao Zhang, will present at the upcoming Roth 20th Annual OC Growth Stock Conference in Dana Point, California.
The date, time and location of Shengtai Pharmaceutical, Inc.'s
presentation at the conference are as follows:
Date: Thursday, February 21, 2008
Time: 10:30 a.m. Pacific Time
Venue: Ritz Ballroom Salon 1
The Ritz Carlton Laguna Niguel
One Ritz-Carlton Drive
Dana Point, California 92629
A replay of the call will be available for 90 days following the presentation using the same link and will also be available on the Company's website.
The ROTH 20th Annual OC Conference will feature presentations from over 300 small-cap companies including over 40 U.S.-listed Chinese companies. The distinguished list of presenting companies have been identified by Roth Capital's award-winning research team and are representative of a broad spectrum of sectors, including Technology, Healthcare, Energy and Industrial as well as Consumer Products.
Interested parties and investors may find more information for the conference by visiting the website at http://www.rothcapital.com.
About Shengtai Pharmaceutical, Inc.
Shengtai Pharmaceutical, Inc. through its wholly-owned subsidiary
Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the holding
company for Weifang Shengtai Pharmaceutical Co., Ltd., is a leading
manufacturer and supplier of glucose products, which include pharmaceutic
|SOURCE Shengtai Pharmaceutical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved